{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T02:25:32Z","timestamp":1779416732018,"version":"3.53.1"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.clnesp.2026.103295","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T23:59:35Z","timestamp":1777161575000},"page":"103295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Molecular pathways and therapeutic frontiers in cancer cachexia: Integrating inflammatory and non-inflammatory mechanisms"],"prefix":"10.1016","volume":"73","author":[{"given":"Anjan","family":"D","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0585-3702","authenticated-orcid":false,"given":"Shaik Nabi","family":"Rasool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay Kumar","family":"M","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.clnesp.2026.103295_bib1","doi-asserted-by":"crossref","first-page":"622","DOI":"10.7326\/0003-4819-133-8-200010170-00015","article-title":"Cachexia","volume":"133","author":"Kotler","year":"2000","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.clnesp.2026.103295_bib2","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.cell.2023.03.028","article-title":"Cachexia: a systemic consequence of progressive, unresolved disease","volume":"186","author":"Ferrer","year":"2023","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.clnesp.2026.103295_bib3","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4103\/apjon.apjon-2126","article-title":"Revisiting cancer cachexia: pathogenesis, diagnosis, and current treatment approaches","volume":"8","author":"Baba","year":"2021","journal-title":"Asia Pac J Oncol Nurs"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103295_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13619-022-00108-9","article-title":"Pathological features of tissues and cell populations during cancer cachexia","volume":"11","author":"Di Girolamo","year":"2022","journal-title":"Cell Regen"},{"issue":"6","key":"10.1016\/j.clnesp.2026.103295_bib5","first-page":"290","article-title":"Cancer cachexia: pathophysiology and association with cancer-related pain, 2022, 3, 971295.Keller U. Pathophysiology of cancer cachexia. Supportive care in cancer","volume":"1","author":"Law","year":"1993","journal-title":"Front Pain Res"},{"issue":"6","key":"10.1016\/j.clnesp.2026.103295_bib6","first-page":"290","article-title":"Pathophysiology of cancer cachexia","volume":"1","author":"Keller","year":"1993","journal-title":"Support Care Cancer"},{"issue":"12","key":"10.1016\/j.clnesp.2026.103295_bib7","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.crad.2016.04.012","article-title":"Evaluation of tumour vascular distribution and function using immunohistochemistry and BOLD fMRI with carbogen inhalation","volume":"71","author":"Xu","year":"2016","journal-title":"Clin Radiol"},{"issue":"4","key":"10.1016\/j.clnesp.2026.103295_bib8","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1097\/MPG.0000000000002050","article-title":"Spectrum of pediatric autoimmune liver disease and validation of its diagnostic scores in Indian children","volume":"67","author":"Sood","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103295_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1196\/annals.1413.008","article-title":"Molecular regulation of lymphatic contractility","volume":"1131","author":"Muthuchamy","year":"2008","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.1016\/j.clnesp.2026.103295_bib10","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.clnesp.2026.103295_bib11","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S2213-8587(13)70180-3","article-title":"Endocrine consequences of anorexia nervosa","volume":"2","author":"Misra","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"14","key":"10.1016\/j.clnesp.2026.103295_bib12","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1024\/1661-8157\/a003348","article-title":"Endocrine consequences of anorexia nervosa","volume":"108","author":"Milos","year":"2019","journal-title":"Praxis"},{"issue":"6","key":"10.1016\/j.clnesp.2026.103295_bib13","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.3892\/mmr.2020.11608","article-title":"Molecular mechanisms of cancer cachexia-induced muscle atrophy","volume":"22","author":"Yang","year":"2020","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.clnesp.2026.103295_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1383203","article-title":"Ferroptosis and the ubiquitin-proteasome system: exploring treatment targets in cancer","volume":"15","author":"Din","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.clnesp.2026.103295_bib15","first-page":"105","volume":"vol. 68","author":"Yang","year":"2021"},{"key":"10.1016\/j.clnesp.2026.103295_bib16","series-title":"Deep manifold learning reveals hidden dynamics of proteasome autoregulation","first-page":"2020","author":"Wu","year":"2020"},{"key":"10.1016\/j.clnesp.2026.103295_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1531797","article-title":"Mechanisms of ubiquitin-independent proteasomal degradation and their roles in age-related neurodegenerative disease","volume":"12","author":"Church","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.clnesp.2026.103295_bib18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fmolb.2019.00048","article-title":"Regulation of proteasome activity by (post-)transcriptional mechanisms","volume":"6","author":"Kors","year":"2019","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.clnesp.2026.103295_bib19","first-page":"4215","article-title":"The ubiquitin receptor Rpn10 functions as a gatekeeper to proteasome degradation","volume":"14","author":"Bhattacharyya","year":"2023","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.clnesp.2026.103295_bib20","article-title":"The role of RPN10 in substrate recognition by the proteasome","volume":"434","author":"Kim","year":"2022","journal-title":"J Mol Biol"},{"issue":"4","key":"10.1016\/j.clnesp.2026.103295_bib21","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.bbamcr.2012.01.002","article-title":"The CCAAT box-binding transcription factor NF-Y regulates basal expression of human proteasome genes","volume":"1823","author":"Xu","year":"2012","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.clnesp.2026.103295_bib22","article-title":"The ubiquitin-proteasome system in the tumor immune microenvironment: a key force in combination therapy","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.clnesp.2026.103295_bib23","doi-asserted-by":"crossref","DOI":"10.2991\/978-94-6463-556-0","article-title":"Ubiquitin proteasome system in cardiac fibrosis","author":"Zeng","year":"2024","journal-title":"J Adv Res"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103295_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/cells13010029","article-title":"Targeting the ubiquitin\u2013proteasome system and recent advances in cancer therapy","volume":"13","author":"Spano","year":"2023","journal-title":"Cells"},{"issue":"16","key":"10.1016\/j.clnesp.2026.103295_bib25","doi-asserted-by":"crossref","first-page":"8872","DOI":"10.3390\/ijms23168872","article-title":"Visualizing conformational space of functional biomolecular complexes by deep manifold learning","volume":"23","author":"Wu","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.clnesp.2026.103295_bib26","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"Mtor signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.clnesp.2026.103295_bib27","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1080\/15548627.2025.2457925","article-title":"Limiting cap-dependent translation increases 20S proteasomal degradation and protects the proteomic integrity in autophagy-deficient skeletal muscle","volume":"21","author":"Dong","year":"2025","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103295_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-73049-9","article-title":"Heme deficiency in skeletal muscle exacerbates sarcopenia and impairs autophagy by reducing AMPK signaling","volume":"14","author":"Akabane","year":"2024","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.clnesp.2026.103295_bib29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.15698\/cst2018.11.163","article-title":"P38\u03b2 MAPK mediates ULK1-dependent induction of autophagy in skeletal muscle of tumor-bearing mice","volume":"2","author":"Liu","year":"2018","journal-title":"Cell Stress"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103295_bib30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13045-023-01454-0","article-title":"Cancer cachexia: molecular mechanisms and treatment strategies","volume":"16","author":"Setiawan","year":"2023","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.clnesp.2026.103295_bib31","series-title":"Autophagy selectively clears ER in inflammation-induced muscle atrophy","first-page":"2025","author":"Dueren","year":"2025"},{"issue":"5","key":"10.1016\/j.clnesp.2026.103295_bib32","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.cmet.2013.03.015","article-title":"Sustained activation of mTORC1 in skeletal muscle inhibits constitutive and starvation-induced autophagy and causes a severe, late-onset myopathy","volume":"17","author":"Castets","year":"2013","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103295_bib33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13045-023-01429-1","article-title":"LCN2 secreted by tissue-infiltrating neutrophils induces the ferroptosis and wasting of adipose and muscle tissues in lung cancer cachexia","volume":"16","author":"Wang","year":"2023","journal-title":"J Hematol Oncol"},{"issue":"12","key":"10.1016\/j.clnesp.2026.103295_bib34","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/nm.4437","article-title":"Enhancing the precision of genetic lineage tracing using dual recombinases","volume":"23","author":"He","year":"2017","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.clnesp.2026.103295_bib35","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1093\/gerona\/glaa146","article-title":"Clinical characteristics of hospitalized individuals dying with COVID-19 by age group in Italy","volume":"75","author":"Palmieri","year":"2020","journal-title":"J Gerontol: ser A"},{"key":"10.1016\/j.clnesp.2026.103295_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s43587-025-00907-0","article-title":"Senescent macrophages induce ferroptosis in skeletal muscle and accelerate osteoarthritis-related muscle atrophy","author":"Xiang","year":"2025","journal-title":"Nat Aging"},{"key":"10.1016\/j.clnesp.2026.103295_bib37","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.freeradbiomed.2022.09.018","article-title":"Thiostrepton confers protection against reactive oxygen species-related apoptosis by restraining FOXM1-triggered development of gastric cancer","volume":"193","author":"Liu","year":"2022","journal-title":"Free Radical Biol Med"},{"key":"10.1016\/j.clnesp.2026.103295_bib38","article-title":"Regulation of skeletal muscle atrophy in cachexia by microRNAs and long non-coding RNAs","volume":"8","author":"Chen","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"12","key":"10.1016\/j.clnesp.2026.103295_bib39","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.bbadis.2013.09.005","article-title":"MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis","volume":"1832","author":"Mao","year":"2013","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"10","key":"10.1016\/j.clnesp.2026.103295_bib40","doi-asserted-by":"crossref","first-page":"E1042","DOI":"10.1152\/ajpendo.00410.2012","article-title":"Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK","volume":"304","author":"White","year":"2013","journal-title":"Am J Physiol Endocrinol Metabol"},{"issue":"4","key":"10.1016\/j.clnesp.2026.103295_bib41","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1194\/jlr.R600021-JLR200","article-title":"The role of TNF-\u03b1 in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk","volume":"48","author":"Popa","year":"2007","journal-title":"J Lipid Res"},{"issue":"8","key":"10.1016\/j.clnesp.2026.103295_bib42","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2217\/imt-2016-0020","article-title":"Immunotherapeutic implications of IL-6 blockade for cytokine storm","volume":"8","author":"Tanaka","year":"2016","journal-title":"Immunotherapy"},{"key":"10.1016\/j.clnesp.2026.103295_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.597675","article-title":"Inflammation and skeletal muscle wasting during cachexia","volume":"11","author":"Webster","year":"2020","journal-title":"Front Physiol"},{"issue":"11","key":"10.1016\/j.clnesp.2026.103295_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114925","article-title":"Muscle inflammation is regulated by NF-\u03baB from multiple cells to control distinct states of wasting in cancer cachexia","volume":"43","author":"Pryce","year":"2024","journal-title":"Cell Rep"},{"issue":"2","key":"10.1016\/j.clnesp.2026.103295_bib45","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2004.09.027","article-title":"IKK\u03b2\/NF-\u03baB activation causes severe muscle wasting in mice","volume":"119","author":"Cai","year":"2004","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.clnesp.2026.103295_bib46","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ccell.2024.03.009","article-title":"The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia","volume":"42","author":"Liu","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.clnesp.2026.103295_bib47","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-25-0293","article-title":"Cancer-associated cachexia: bridging clinical findings with mechanistic insights in human studies","author":"Koh","year":"2025","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103295_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70030","article-title":"Sarcopenia and cachexia: molecular mechanisms and therapeutic interventions","volume":"6","author":"Wang","year":"2025","journal-title":"MedComm"},{"issue":"5488","key":"10.1016\/j.clnesp.2026.103295_bib49","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1126\/science.289.5488.2363","article-title":"NF-\u03baB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia","volume":"289","author":"Guttridge","year":"2000","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.clnesp.2026.103295_bib50","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.trecan.2019.07.010","article-title":"Impaired muscle regeneration in cancer-associated cachexia","volume":"5","author":"Arneson","year":"2019","journal-title":"Trends Cancer"},{"issue":"3","key":"10.1016\/j.clnesp.2026.103295_bib51","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1096\/fj.11-189977","article-title":"Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy","volume":"26","author":"Reed","year":"2012","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.clnesp.2026.103295_bib52","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0092-8674(04)00400-3","article-title":"Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy","volume":"117","author":"Sandri","year":"2004","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103295_bib53","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1042\/bj3600143","article-title":"Identification of cathepsin L as a differentially expressed message associated with skeletal muscle wasting","volume":"360","author":"Deval","year":"2001","journal-title":"Biochem J"},{"issue":"3","key":"10.1016\/j.clnesp.2026.103295_bib54","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/oxfordjournals.jbchem.a021794","article-title":"Involvement of interleukin-6 in activation of lysosomal cathepsin and atrophy of muscle fibers induced by intramuscular injection of turpentine oil in mice","volume":"122","author":"Tsujinaka","year":"1997","journal-title":"J Biochem"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103295_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94565-y","article-title":"The role of IL-1 in adipose browning and muscle wasting in CKD-associated cachexia","volume":"11","author":"Cheung","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.clnesp.2026.103295_bib56","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s10753-021-01429-8","article-title":"The emerging role of interleukin 1\u03b2 (IL-1\u03b2) in cancer cachexia","volume":"44","author":"Laird","year":"2021","journal-title":"Inflammation"},{"key":"10.1016\/j.clnesp.2026.103295_bib57","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jare.2023.04.018","article-title":"Immunoregulation in cancer-associated cachexia","volume":"58","author":"Wu","year":"2024","journal-title":"J Adv Res"},{"issue":"3","key":"10.1016\/j.clnesp.2026.103295_bib58","doi-asserted-by":"crossref","first-page":"R659","DOI":"10.1152\/ajpregu.1989.256.3.R659","article-title":"Cachectin\/TNF or IL-1 alpha induces cachexia with redistribution of body proteins","volume":"256","author":"Fong","year":"1989","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.clnesp.2026.103295_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.597675","article-title":"Inflammation and skeletal muscle wasting during cachexia","volume":"11","author":"Webster","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.clnesp.2026.103295_bib60","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.semcdb.2015.10.038","article-title":"The central role of hypothalamic inflammation in the acute illness response and cachexia","volume":"54","author":"Burfeind","year":"2016","journal-title":"Semin Cell Dev Biol"},{"issue":"12","key":"10.1016\/j.clnesp.2026.103295_bib61","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nri3766","article-title":"The IL-20 subfamily of cytokines\u2014from host defence to tissue homeostasis","volume":"14","author":"Rutz","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.clnesp.2026.103295_bib62","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1152\/ajpendo.00039.2012","article-title":"JAK\/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia","volume":"303","author":"Bonetto","year":"2012","journal-title":"Am J Physiol Endocrinol Metabol"},{"issue":"7","key":"10.1016\/j.clnesp.2026.103295_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022538","article-title":"STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia","volume":"6","author":"Bonetto","year":"2011","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.clnesp.2026.103295_bib64","first-page":"4009","article-title":"The role of interleukin-6 family cytokines in cancer cachexia","volume":"291","author":"Agca","year":"2024","journal-title":"FEBS J"},{"key":"10.1016\/j.clnesp.2026.103295_bib65","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3389\/fphys.2019.00500","article-title":"The JAK\/STAT pathway in skeletal muscle pathophysiology","volume":"10","author":"Moresi","year":"2019","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103295_bib66","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1172\/JCI118387","article-title":"Mechanism of impaired glucose-potentiated insulin secretion in diabetic 90% pancreatectomy rats: study using glucagonlike peptide-1 (7-37)","volume":"97","author":"Ya","year":"1996","journal-title":"J Clin Investig"},{"issue":"78","key":"10.1016\/j.clnesp.2026.103295_bib67","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.26190","article-title":"Leukemia inhibitory factor via the Toll-like receptor 5 signaling pathway involves aggravation of cachexia induced by human gastric cancer-derived 85As2 cells in rats","volume":"9","author":"Terawaki","year":"2018","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.clnesp.2026.103295_bib68","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1152\/physrev.00016.2008","article-title":"Mechanisms of cancer cachexia","volume":"89","author":"Tisdale","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1016\/j.clnesp.2026.103295_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.841758","article-title":"Cytokine-mediated STAT3 transcription supports ATGL\/CGI-58-dependent adipocyte lipolysis in cancer cachexia","volume":"12","author":"Gandhi","year":"2022","journal-title":"Front Oncol"},{"issue":"5115","key":"10.1016\/j.clnesp.2026.103295_bib70","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1126\/science.8511589","article-title":"IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase","volume":"260","author":"Murakami","year":"1993","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103295_bib71","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"18","key":"10.1016\/j.clnesp.2026.103295_bib72","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1158\/0008-5472.CAN-15-3152","article-title":"Differential effects of IL6 and activin A in the development of cancer-associated cachexia","volume":"76","author":"Chen","year":"2016","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.clnesp.2026.103295_bib73","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/nm.2247","article-title":"Autophagy is defective in collagen VI muscular dystrophies, and its reactivation rescues myofiber degeneration","volume":"16","author":"Grumati","year":"2010","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103295_bib74","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.urology.2006.09.039","article-title":"Interleukin 6 is associated with cachexia in patients with prostate cancer","volume":"69","author":"Kuroda","year":"2007","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.clnesp.2026.103295_bib75","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1189\/jlb.0410226","article-title":"More than a sidekick: the IL-6 family cytokine IL-11 links inflammation to cancer","volume":"88","author":"Putoczki","year":"2010","journal-title":"J Leukoc Biol"},{"issue":"2","key":"10.1016\/j.clnesp.2026.103295_bib76","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ccr.2013.06.017","article-title":"Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically","volume":"24","author":"Putoczki","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.clnesp.2026.103295_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110509","article-title":"Interleukin-11 (IL11) inhibits myogenic differentiation of C2C12 cells through activation of extracellular signal-regulated kinase (ERK)","volume":"101","author":"Drinkwater","year":"2023","journal-title":"Cell Signal"},{"issue":"6","key":"10.1016\/j.clnesp.2026.103295_bib78","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/sj.bjc.6601132","article-title":"Increased expression of the ubiquitin\u2013proteasome pathway in murine myotubes by proteolysis-inducing factor (PIF) is associated with activation of the transcription factor NF-\u03baB","volume":"89","author":"Whitehouse","year":"2003","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.clnesp.2026.103295_bib79","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/bjc.2014.379","article-title":"Functional identity of receptors for proteolysis-inducing factor on human and murine skeletal muscle","volume":"111","author":"Mirza","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clnesp.2026.103295_bib80","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fphys.2014.00088","article-title":"Pancreatic cancer cachexia: a review of mechanisms and therapeutics","volume":"5","author":"Tan","year":"2014","journal-title":"Front Physiol"},{"issue":"6","key":"10.1016\/j.clnesp.2026.103295_bib81","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s11010-022-04398-0","article-title":"The burning furnace: alteration in lipid metabolism in cancer-associated cachexia","volume":"477","author":"Joshi","year":"2022","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103295_bib82","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/s41467-020-20123-1","article-title":"Mechanisms of muscle atrophy and hypertrophy: implications in health and disease","volume":"12","author":"Sartori","year":"2021","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.clnesp.2026.103295_bib83","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022236","article-title":"Regulation of the immune response by TGF-\u03b2: from conception to autoimmunity and infection","volume":"9","author":"Sanjabi","year":"2017","journal-title":"Cold Spring Harbor Perspect Biol"},{"issue":"2","key":"10.1016\/j.clnesp.2026.103295_bib84","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1017\/S0007114521003962","article-title":"Adipokines: inflammation and the pleiotropic role of white adipose tissue","volume":"127","author":"Trayhurn","year":"2022","journal-title":"Br J Nutr"},{"issue":"11","key":"10.1016\/j.clnesp.2026.103295_bib85","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: understanding the molecular basis","volume":"14","author":"Argil\u00e9s","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103295_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2302\/kjm.60.1","article-title":"Leptin and the regulation of body weigh","volume":"60","author":"Friedman","year":"2011","journal-title":"Keio J Med"},{"issue":"6","key":"10.1016\/j.clnesp.2026.103295_bib87","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103295_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/endrev\/bnae021","article-title":"Adiponectin and adiponectin receptors in atherosclerosis","volume":"46","author":"Gianopoulos","year":"2025","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.clnesp.2026.103295_bib89","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11154-013-9283-3","article-title":"Adiponectin and energy homeostasis","volume":"15","author":"Lee","year":"2014","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"10.1016\/j.clnesp.2026.103295_bib90","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3390\/cancers12030634","article-title":"In vivo and in vitro anticancer activity of doxorubicin-loaded DNA-AuNP nanocarrier for the ovarian cancer treatment","volume":"12","author":"Lee","year":"2020","journal-title":"Cancers"},{"issue":"5708","key":"10.1016\/j.clnesp.2026.103295_bib91","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.1097243","article-title":"Visfatin: a protein secreted by visceral fat that mimics the effects of insulin","volume":"307","author":"Fukuhara","year":"2005","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103295_bib92","first-page":"57","article-title":"Adipose tissue, obesity and adipokines: role in cancer promotion","volume":"21","author":"Booth","year":"2015","journal-title":"Horm Mol Biol Clin Invest"},{"issue":"8","key":"10.1016\/j.clnesp.2026.103295_bib93","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrendo.2012.49","article-title":"Muscles, exercise and obesity: skeletal muscle as a secretory organ","volume":"8","author":"Pedersen","year":"2012","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"10.1016\/j.clnesp.2026.103295_bib94","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.clnesp.2026.103295_bib95","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/jcp.30033","article-title":"Myokines mediate the cross talk between skeletal muscle and other organs","volume":"236","author":"Chen","year":"2021","journal-title":"J Cell Physiol"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103295_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3230001","article-title":"Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling","volume":"323","author":"Faergeman","year":"1997","journal-title":"Biochem J"},{"issue":"9","key":"10.1016\/j.clnesp.2026.103295_bib97","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13910","article-title":"Acyl coenzyme A binding protein (ACBP): an aging-and disease-relevant \u201cautophagy checkpoint\u201d","volume":"22","author":"Mont\u00e9gut","year":"2023","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103295_bib98","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12943-024-02098-5","article-title":"Acyl-coenzyme a binding protein (ACBP)\u2014A risk factor for cancer diagnosis and an inhibitor of immunosurveillance","volume":"23","author":"Mont\u00e9gut","year":"2024","journal-title":"Mol Cancer"},{"issue":"8","key":"10.1016\/j.clnesp.2026.103295_bib99","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.3390\/biomedicines13081931","article-title":"The multifaceted role of growth differentiation factor 15 (GDF15): a narrative review from cancer cachexia to target therapy","volume":"13","author":"Filippini","year":"2025","journal-title":"Biomedicines"},{"issue":"10","key":"10.1016\/j.clnesp.2026.103295_bib100","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1056\/NEJMc2500502","article-title":"Ponsegromab for the treatment of cancer cachexia","volume":"392","author":"Dufour","year":"2025","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.clnesp.2026.103295_bib101","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ejca.2008.02.033","article-title":"Cancer cachexia: developing multimodal therapy for a multidimensional problem","volume":"44","author":"Fearon","year":"2008","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103295_bib102","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","article-title":"ESPEN guidelines on nutrition in cancer patients","volume":"36","author":"Arends","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnesp.2026.103295_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123125","article-title":"Bortezomib in cancer therapy: mechanisms, side effects, and future proteasome inhibitors","volume":"358","author":"Sogbein","year":"2024","journal-title":"Life Sci"},{"key":"10.1016\/j.clnesp.2026.103295_bib104","doi-asserted-by":"crossref","DOI":"10.53941\/ijddp.2024.100004","article-title":"Development of proteasome inhibitors for cancer therapy","author":"Chen","year":"2024","journal-title":"Int J drug discov Pharmacol"},{"key":"10.1016\/j.clnesp.2026.103295_bib105","article-title":"The evolution and diversification of proteasome inhibitors in cancer and beyond","author":"Rahimi","year":"2025","journal-title":"Chem"},{"issue":"8","key":"10.1016\/j.clnesp.2026.103295_bib106","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.3390\/nu16081246","article-title":"Treatment of cachexia in gastric cancer: exploring the use of anti-inflammatory natural products and their derivatives","volume":"16","author":"Loyala","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.clnesp.2026.103295_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.freeradbiomed.2025.08.043","article-title":"Exercise training ameliorates high-fat diet-induced skeletal muscle atrophy and ferroptosis via downregulation of STING","author":"Xu","year":"2025","journal-title":"Free Radical Biol Med"},{"issue":"4","key":"10.1016\/j.clnesp.2026.103295_bib108","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1113\/JP287090","article-title":"Pharmacological reduction of lipid hydroperoxides as a potential modulator of sarcopenia","volume":"603","author":"Brown","year":"2025","journal-title":"J Physiol"},{"key":"10.1016\/j.clnesp.2026.103295_bib109","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1582216","article-title":"Deferoxamine prevents dexamethasone-induced muscle atrophy by reducing MuRF1 and atrogin-1","volume":"16","author":"Jeong","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.clnesp.2026.103295_bib110","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-24-3420","article-title":"Blocking NRF2 translation by inhibition of cap-dependent initiation sensitizes lymphoma cells to ferroptosis and CAR T-cell immunotherapy","author":"Manara","year":"2025","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103295_bib111","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1515\/rir-2024-0009","article-title":"Not all geriatric cachexia is cancer\u2014the difficult late-onset rheumatoid arthritis","volume":"5","author":"Correia","year":"2024","journal-title":"Rheumatol Immunol Res"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103295_bib112","article-title":"Evaluation of methods employed in establishing preclinical similarity of adalimumab biosimilars","volume":"2025","author":"Nair","year":"2025","journal-title":"Adv Pharmacol Pharmaceutical Sci"},{"issue":"6","key":"10.1016\/j.clnesp.2026.103295_bib113","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/jcsm.13638","article-title":"Tocilizumab for advanced non-small-cell lung cancer with concomitant cachexia: an observational study","volume":"15","author":"Du","year":"2024","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"14","key":"10.1016\/j.clnesp.2026.103295_bib114","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.clnesp.2026.103295_bib115","doi-asserted-by":"crossref","first-page":"7896","DOI":"10.3390\/ijms22157896","article-title":"Genomic variability in the survival motor neuron genes (SMN1 and SMN2): implications for spinal muscular atrophy phenotype and therapeutics development","volume":"22","author":"Butchbach","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"7516","key":"10.1016\/j.clnesp.2026.103295_bib116","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature13528","article-title":"Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia","volume":"513","author":"Kir","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.clnesp.2026.103295_bib117","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2409515","article-title":"Ponsegromab in cancer cachexia","author":"Groarke","year":"2024","journal-title":"N Engl J Med"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457726003918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457726003918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T01:42:10Z","timestamp":1779414130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457726003918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":117,"alternative-id":["S2405457726003918"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2026.103295","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular pathways and therapeutic frontiers in cancer cachexia: Integrating inflammatory and non-inflammatory mechanisms","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2026.103295","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103295"}}